Zymeworks (ZYME) Amortizatization of Intangibles (2021 - 2026)
Powered by 
Analysis
Zymeworks (ZYME) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Zymeworks | 2.13 Bn | 1.86 Bn | - | 821,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 821,000.00 |
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | 924,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 723,000.00 |
| Mar 31, 2025 | 707,000.00 |
| Dec 31, 2024 | 690,000.00 |
| Sep 30, 2024 | 648,000.00 |
| Jun 30, 2024 | 622,000.00 |
| Mar 31, 2024 | 549,000.00 |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 637,000.00 |
| Dec 31, 2022 | 627,000.00 |
| Sep 30, 2022 | 642,000.00 |
| Jun 30, 2022 | 635,000.00 |
| Mar 31, 2022 | 2.87 Mn |
| Dec 31, 2021 | 447,000.00 |